Tetradox 100 Teva Pharmaceutical — Research Summary
Tetradox 100 is a doxycycline hyclate formulation manufactured by Teva Pharmaceutical for in-vitro laboratory research examining antibiotic mechanisms and bacterial resistance pathways. Doxycycline is a broad-spectrum tetracycline antibiotic that researchers study for its protein synthesis inhibition properties at the ribosomal level. This pharmaceutical-grade compound enables detailed investigation of antimicrobial activity patterns, resistance gene expression, and bacteriostatic mechanisms in controlled laboratory environments. Research scientists examine this formulation for its stability characteristics and bioactivity profiles in microbiological studies.
Research institutions utilise this compound to investigate bacterial protein synthesis pathways and examine the molecular mechanisms underlying antibiotic resistance development. The standardised formulation allows researchers to evaluate antimicrobial efficacy against various bacterial strains and study the compound’s interaction with ribosomal RNA structures. Scientists at Stroid UK Shop examine how this antibiotic affects bacterial growth patterns and investigate its potential applications in antimicrobial research protocols.
Laboratory Applications
Laboratory researchers study Tetradox 100 for investigating bacterial susceptibility testing, examining minimum inhibitory concentration thresholds, and evaluating antimicrobial resistance mechanisms. Scientists analyse this compound’s effects on various bacterial species to understand protein synthesis disruption patterns and examine how bacteria develop resistance through ribosomal protection mechanisms. Research applications include studying tetracycline resistance gene expression, examining efflux pump activity, and investigating the compound’s interaction with bacterial 30S ribosomal subunits.
Microbiologists examine this formulation for research into bacterial biofilm formation, investigating how doxycycline affects bacterial community structures and examining its potential in combination therapy studies. The compound serves as a reference standard in pharmaceutical research examining tetracycline class antibiotics and their mechanisms of action. Research teams study its pharmacokinetic properties and examine how different bacterial species respond to various concentration levels in controlled laboratory conditions.
Analytical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Doxycycline Hyclate |
| Strength | 100mg per unit |
| Manufacturer | Teva Pharmaceutical |
| Form | Tablet formulation |
| CAS Number | 24390-14-5 |
| Molecular Formula | C₂₂H₂₄N₂O₈·HCl·½H₂O |
| Storage | Room temperature, dry environment |
| Research Use | In-vitro applications only |
Research teams studying antimicrobial compounds often examine this formulation alongside selective receptor modulators and bioactive peptides to understand different molecular pathway interactions in laboratory settings.
Research Compliance
Tetradox 100 is supplied exclusively for in-vitro research applications and laboratory analysis. This pharmaceutical formulation is not intended for human consumption, clinical applications, or therapeutic use. Researchers must handle this compound according to established laboratory safety protocols and store it under appropriate conditions to maintain analytical integrity. All research applications must comply with relevant laboratory regulations and institutional review board requirements for antimicrobial research studies.
